Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
This article contains data on clinical endpoints (Peak Flow Expiratory Rate, fractional exhaled nitric oxide and total IgE serum levels) and plasma pharmacokinetic parameters concerning the use of the oral CRTh2 antagonist QAW039 (fevipiprant) in mild to moderate asthma patients. Information on expe...
Main Authors: | Veit J. Erpenbeck, Todor A. Popov, David Miller, Steven F. Weinstein, Sheldon Spector, Baldur Magnusson, Wande Osuntokun, Paul Goldsmith, Markus Weiss, Jutta Beier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340916305406 |
Similar Items
-
Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)
by: Mario Castro, et al.
Published: (2021-05-01) -
2'-[(4-Fluorophenyl)carbonyl]-1'-phenyl-1',2',5',6',7',7a'-hexahydrospiro[indole-3,3'-pyrrolizin]-2(1H)-one
by: Majal Sapnakumari, et al.
Published: (2013-05-01) -
Role of Thermal Process on Self-Assembled Structures of 4'-([2,2':6',2''-Terpyridin]-4'-Yl)-[1,1'-Biphenyl]-4-Carboxylic Acid on Au(III)
by: Li Wang, et al.
Published: (2013-03-01) -
Solid-State Synthesis of Poly(3',4'-dimethoxy-2,2':5',2"- terthiophene): Comparison With Poly(terthiophene) and Poly(3',4'-ethylenedioxy-2,2':5',2"- terthiophene)
by: Ismayil Nurulla, et al.
Published: (2012-07-01) -
CRTH2 antagonists in asthma: current perspectives
by: Singh D, et al.
Published: (2017-12-01)